These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25713431)

  • 41. Tubal Ligation and Risk of Endometrial Cancer: Findings From the Women's Health Initiative.
    Winer I; Lehman A; Wactawski-Wende J; Robinson R; Simon M; Cote M
    Int J Gynecol Cancer; 2016 Mar; 26(3):464-71. PubMed ID: 26825831
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bisphosphonate Use and Risk of Recurrence, Second Primary Breast Cancer, and Breast Cancer Mortality in a Population-Based Cohort of Breast Cancer Patients.
    Korde LA; Doody DR; Hsu L; Porter PL; Malone KE
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):165-173. PubMed ID: 29254937
    [No Abstract]   [Full Text] [Related]  

  • 43. Association between diabetes, diabetes treatment and risk of developing endometrial cancer.
    Luo J; Beresford S; Chen C; Chlebowski R; Garcia L; Kuller L; Regier M; Wactawski-Wende J; Margolis KL
    Br J Cancer; 2014 Sep; 111(7):1432-9. PubMed ID: 25051408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease.
    Tiihonen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
    J Alzheimers Dis; 2016; 52(1):127-32. PubMed ID: 26967224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A prospective study of bisphosphonate use and risk of colorectal cancer.
    Khalili H; Huang ES; Ogino S; Fuchs CS; Chan AT
    J Clin Oncol; 2012 Sep; 30(26):3229-33. PubMed ID: 22649131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of oral contraceptives and endometrial cancer risk (Sweden).
    Weiderpass E; Adami HO; Baron JA; Magnusson C; Lindgren A; Persson I
    Cancer Causes Control; 1999 Aug; 10(4):277-84. PubMed ID: 10482486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk.
    Newcomb PA; Trentham-Dietz A; Hampton JM
    Br J Cancer; 2010 Mar; 102(5):799-802. PubMed ID: 20160722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bisphosphonates and glucose homeostasis: a population-based, retrospective cohort study.
    Toulis KA; Nirantharakumar K; Ryan R; Marshall T; Hemming K
    J Clin Endocrinol Metab; 2015 May; 100(5):1933-40. PubMed ID: 25695881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reply to F. Tomao et al.
    Newcomb PA; Passarelli MN
    J Clin Oncol; 2015 Nov; 33(31):3670-1. PubMed ID: 26282645
    [No Abstract]   [Full Text] [Related]  

  • 50. Physical activity and risk of endometrial cancer in a prospective cohort study (United States).
    Colbert LH; Lacey JV; Schairer C; Albert P; Schatzkin A; Albanes D
    Cancer Causes Control; 2003 Aug; 14(6):559-67. PubMed ID: 12948287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of bisphosphonates and reduced risk of colorectal cancer.
    Rennert G; Pinchev M; Rennert HS; Gruber SB
    J Clin Oncol; 2011 Mar; 29(9):1146-50. PubMed ID: 21321296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral bisphosphonates and incidence of cancers in patients with osteoporosis: a systematic review and meta-analysis.
    Deng Y; Zhang Z; Jia X; Cheng W; Zhou X; Liu Y; Wang M
    Arch Osteoporos; 2018 Dec; 14(1):1. PubMed ID: 30560459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bisphosphonates and risk of cancers: a systematic review and meta-analysis.
    Li YY; Gao LJ; Zhang YX; Liu SJ; Cheng S; Liu YP; Jia CX
    Br J Cancer; 2020 Nov; 123(10):1570-1581. PubMed ID: 32901134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exposure to bisphosphonates and risk of common non-gastrointestinal cancers: series of nested case-control studies using two primary-care databases.
    Vinogradova Y; Coupland C; Hippisley-Cox J
    Br J Cancer; 2013 Aug; 109(3):795-806. PubMed ID: 23868009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A population-based cohort study on sun habits and endometrial cancer.
    Epstein E; Lindqvist PG; Geppert B; Olsson H
    Br J Cancer; 2009 Aug; 101(3):537-40. PubMed ID: 19550419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identifying High-Risk Women for Endometrial Cancer Prevention Strategies: Proposal of an Endometrial Cancer Risk Prediction Model.
    Kitson SJ; Evans DG; Crosbie EJ
    Cancer Prev Res (Phila); 2017 Jan; 10(1):1-13. PubMed ID: 27965288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Family history of breast cancer as a determinant of the risk of developing endometrial cancer: a nationwide cohort study.
    Kazerouni N; Schairer C; Friedman HB; Lacey JV; Greene MH
    J Med Genet; 2002 Nov; 39(11):826-32. PubMed ID: 12414823
    [No Abstract]   [Full Text] [Related]  

  • 58. Endometrial cancer incidence and oral contraception.
    Nischan P; Ebeling K
    Int J Epidemiol; 1991 Sep; 20(3):820-1. PubMed ID: 1955271
    [No Abstract]   [Full Text] [Related]  

  • 59. Bisphosphonate therapy and orthodontics: implications for postmenopausal women.
    Listik E; Giro G; Negrisoli S; Rodrigues IV; Duarte PM; Nahás-Scocate ACR
    J Clin Orthod; 2022 Mar; 56(3):175-182. PubMed ID: 35706149
    [No Abstract]   [Full Text] [Related]  

  • 60. Bisphosphonates and esophageal cancer--a pathway through the confusion.
    Dixon WG; Solomon DH
    Nat Rev Rheumatol; 2011 Jun; 7(6):369-72. PubMed ID: 21537362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.